Nomura Holdings
ATNM icon

Nomura Holdings’s Actinium Pharmaceuticals ATNM Stock Holding History

Nomura Holdings’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-798
Closed -$43K – 1176
2016
Q2 		$43K Buy
798
+131
+20% +$7.31K ﹤0.01% 1167
2016
Q1 		$41K Buy
+667
New +$42.1K ﹤0.01% 1461

Other funds holding ATNM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nomura Holdings's ATNM Position: Q3 2016 in Review

Nomura Holdings sold out of Actinium Pharmaceuticals (ATNM) in Q3 2016, closing a stake of 798 shares — an estimated $43K sold.

Nomura Holdings first reported a position in ATNM in Q1 2016 and held it in 2 quarters. The position peaked at $43K in Q2 2016. 30 funds tracked by Wall St. Rank hold ATNM as of Q3 2016.

  • Nomura Holdings reported no remaining Actinium Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Nomura Holdings sold 798 Actinium Pharmaceuticals shares in Q3 2016, an estimated $43K.
  • Nomura Holdings first reported a position in Actinium Pharmaceuticals in Q1 2016 and held it in 2 quarters.
  • Nomura Holdings's Actinium Pharmaceuticals position peaked at $43K in Q2 2016.
  • 30 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q3 2016.

Based on Nomura Holdings's 13F filing for Q3 2016, filed 14 Nov 2016.